REQUEST A DEMO
Total
USD $0.00
Search more companies

Venmax Drugs & Pharmaceuticals Ltd. (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Venmax Drugs & Pharmaceuticals Ltd. Profile Updated: November 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Venmax Drugs & Pharmaceuticals Ltd. is a pharmaceutical company based in Hyderabad, India. It was initially incorporated as a private limited company under the name "Yenkay Medico Private Limited" on September 28, 1998. The company later changed its name to "Yenkey Drugs & Pharmaceuticals Private Limited" on January 18, 1995, and became a public limited company on February 3, 1995, under the name "Yenkey Drugs & Pharmaceuticals Ltd." Finally, on April 13, 2009, the company changed its name to "Venmax Drugs & Pharmaceuticals Ltd." The company has been focused on establishing a chain of medical stores called "Ananya Pharma" under Venmax Drugs & Pharma Ltd. It has already established three shops and plans to expand to 50 in and around Hyderabad. The company is also developing oncology products in its research and development department. It is planning to establish a manufacturing unit with a cGMP facility at the Pharma Cluster in Hyderabad to meet export demand. Venmax Drugs & Pharmaceuticals Ltd. manufactures and sells pharmaceuticals and bulk drugs in India. It was formerly known as Yenkey Drugs & Pharmaceuticals Ltd. and changed its name to Venmax Drugs & Pharmaceuticals Ltd. in 2009. The company was incorporated in 1988 and is based in Hyderabad, India. The company is classified as a non-government company and is registered at the Registrar of Companies in Hyderabad. Its authorized share capital is Rs. 80,000,000 and its paid-up capital is Rs. 52,389,300. The company is involved in the manufacture of other chemical products. The directors of Venmax Drugs & Pharmaceuticals Ltd. are Raj Kumar Rai, Ramakrishnaiah Appanaboyana, and Nooka Krishnaiah. The company's corporate identification number is L24230TG1988PLC009102, and its registration number is 9102. Its email address is venmaxdrugs@gmail.com, and its registered address is Shed No.22, Plot No.84, Phase - 1 IDA Cherlapally Hyderabad Rangareddi TG 500051 IN. The current status of Venmax Drugs & Pharmaceuticals Ltd. is active.

Legal Address
Shed No.22, Plot No.84, Phase - 1,, IDA Cherlapally, Rangareddi,
Hyderabad; Telangana; Postal Code: 500051

Contact Details: Purchase the Venmax Drugs & Pharmaceuticals Ltd. report to view the information.

Website: http://www.venmaxdrugs.com

Basic Information
Total Employees:
Purchase the Venmax Drugs & Pharmaceuticals Ltd. report to view the information.
Outstanding Shares:
Purchase the Venmax Drugs & Pharmaceuticals Ltd. report to view the information.
Registered Capital:
Purchase the Venmax Drugs & Pharmaceuticals Ltd. report to view the information.
Financial Auditors:
Purchase the Venmax Drugs & Pharmaceuticals Ltd. report to view the information.
Incorporation Date:
1988
Key Executives
Purchase this report to view the information.
Chairman & Executive Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
65.67%
Purchase this report to view the information.
23.13%
Purchase this report to view the information.
11.04%
Purchase this report to view the information.
0.15%
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Venmax Drugs & Pharmaceuticals Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Total operating revenue
-52.64%
Operating profit (EBIT)
-61.5%
EBITDA
-59.75%
Net Profit (Loss) for the Period
-71.41%
Total assets
-61.49%
Total equity
9.01%
Return on Equity (ROE)
21.65%
Debt to Equity Ratio
-0.09%
Quick Ratio
-0.13%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?